| 2026年中报 | 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 药品贸易收入(元) | 12,571,008.27 | 21,911,391.45 | 17,255,783.31 | 34,300,370.31 | 27,520,330.01 |
| 综合制剂产品(元) | 105,689,980.21 | 210,017,033.44 | 105,320,404.04 | 190,650,373.91 | 97,119,158.13 |
| 营业成本(元) | |||||
| 药品贸易收入(元) | 9,045,391.53 | 18,845,193.69 | 13,316,119.87 | 25,543,830.67 | 23,094,681.15 |
| 综合制剂产品(元) | 36,570,983.49 | 70,859,725.84 | 36,185,774.06 | 65,609,351.13 | 31,620,243.75 |
| 毛利(元) | |||||
| 药品贸易收入(元) | 3,525,616.74 | 3,066,197.76 | 3,939,663.44 | 8,756,539.64 | 4,425,648.86 |
| 综合制剂产品(元) | 69,118,996.72 | 139,157,307.60 | 69,134,629.98 | 125,041,022.78 | 65,498,914.38 |
| 毛利率(%) | |||||
| 药品贸易收入(%) | 28.05 | 13.99 | 22.83 | 25.53 | 16.08 |
| 综合制剂产品(%) | 65.40 | 66.26 | 65.64 | 65.59 | 67.44 |
| 收入构成(%) | |||||
| 药品贸易收入(%) | 10.63 | 9.45 | 14.08 | 15.25 | 22.08 |
| 综合制剂产品(%) | 89.37 | 90.55 | 85.92 | 84.75 | 77.92 |
| 毛利构成(%) | |||||
| 药品贸易收入(%) | 4.85 | 2.16 | 5.39 | 6.54 | 6.33 |
| 综合制剂产品(%) | 95.15 | 97.84 | 94.61 | 93.46 | 93.67 |